Metagenomi Therapeutics, Inc. (MGX)

CIK 1785279 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Metagenomi Therapeutics, Inc..

Recent SEC filings

FiledFormAccession number
Sep 11, 202640001193125-26-389550
Sep 10, 202640001193125-26-387816
Sep 10, 202640001193125-26-387786
Sep 10, 202640001193125-26-387798
Sep 10, 2026SCHEDULE 13G0001193125-26-387853
Aug 10, 20268-K0001193125-26-342388
Aug 10, 202610-Q0001193125-26-342400
Jun 11, 202640001193125-26-267170
Jun 11, 202640001193125-26-267189
Jun 11, 202640001193125-26-267272
Jun 11, 202640001193125-26-267255
Jun 10, 202640001193125-26-265335
Jun 10, 20268-K0001193125-26-264392
Jun 10, 202640001193125-26-265326
Jun 10, 202640001193125-26-265332
May 11, 202610-Q0001193125-26-216774
May 11, 20268-K0001193125-26-216763
Apr 27, 2026DEFA14A0001193125-26-182339
Apr 27, 2026ARS0001193125-26-182345
Apr 27, 2026DEF 14A0001193125-26-182325
Apr 3, 202640001193125-26-141867
Apr 3, 202640001193125-26-141946
Apr 3, 202640001193125-26-141914
Mar 9, 202640001193125-26-098824
Mar 9, 202640001193125-26-098821